The Rockets traded Alstom. Although all the "bricks and mortar" were screaming, they smiled and thought that this transaction would happen sooner or later. And it should not be as bad as you think.
The biggest cancer of the rocket is MD, but since it cannot be sold out, it is impossible to wait until the contract expires.
Who is the rocket 2 cancer? It's Alstom. The instability of the rocket is closely related to him. Alstom played well most of the time, but the key ball was not well handled and the ability to break through the ball was slightly poor, leading to a high possibility of problems with Alstom at the crucial time.
Tom is playing well now. Although there are some problems, I think the goal of the rockets should be to wait for McGrady's contract to expire, get a defender, and reinforce the center position.
In any case, I am optimistic that the rockets without MD and Alstom should have a good performance this year as long as others are healthy. Leave a post to commemorate it.